Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137160368> ?p ?o ?g. }
- W3137160368 abstract "Background: Although asthmatic patients with chest tightness as their only presenting symptom (chest tightness variant asthma, CTVA) have clinical characteristics of eosinophilic airway inflammation similar to those of classic asthma (CA), the response of CTVA to treatment regimens used for CA is unclear. Methods: To explore the clinical course and response of 96 CTVA patients to standard asthma treatments with inhaled corticosteroids with long-acting beta-agonists in a 52-week multicenter, prospective, real-life study. Findings: After 52 weeks of treatment with therapy regimens used for CA, the 5-point Asthma Control Questionnaire (ACQ-5) scores decreased markedly from 1·34±0·88(before treatment; V0) to 0·97±0·70 (4 weeks, V1), 0·83±0·72 (13 weeks, V2), 0·73±0·76 (26 weeks, V3), and 0·76±0·79(52 weeks, V4) ( P <0·01), while the Asthma Quality of Life Questionnaire (AQLQ) scores increased from 5·76±0·76 (V0) to 6·24±0·60(V3) and 6·14±0·60(V4) ( P <0·01). The Self-rating Anxiety Scale(SAS) score improved as evidenced by a decrease from 41·44±10·24 (V0) to 37·61±11·41 (V2) and 37·67±8·07 (V4) ( P <0·01). Diurnal variation in peak expiratory flow (PEF) and the bronchial provocation test were improved at one year. However, forced expiratory volume (FEV1) andnitric oxide levels in exhaled breath (FeNO) showed no improvement. Interpretation CTVA patients showed a good clinical response to anti-asthma treatments, and the treatment effects may be related to theseverity of CTVA.Interpretation: CTVA patients showed a good clinical response to antiasthma treatments, and the treatment effects may be related to the severity of CTVA. Trial Registration: ClinicalTrials.gov identifier: NCT 03237221Funding: 1.This study was supported by the Zhejiang Medical and Health Science and Technology program from Health Commission of Zhejiang Province (WKJ2014-ZJ-01412). 2.This work was funded by the Precision Medicine Research of The National Key Research and Development Plan of China (2016YFC0905800). 3.This study was supported by the program for the Key Site of National Clinical Research Center for Respiratory Disease, the Key ScienceTechnology Innovation Team of Zhejiang Province (2011R50016).Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: The study was approved by the Institutional Review Board for Human Studies of Second Affiliated Hospital of Zhejiang University School of Medicine (Hangzhou, China)." @default.
- W3137160368 created "2021-03-29" @default.
- W3137160368 creator A5000830943 @default.
- W3137160368 creator A5001969147 @default.
- W3137160368 creator A5003889868 @default.
- W3137160368 creator A5005975071 @default.
- W3137160368 creator A5006063703 @default.
- W3137160368 creator A5012677271 @default.
- W3137160368 creator A5012718640 @default.
- W3137160368 creator A5013429539 @default.
- W3137160368 creator A5013624090 @default.
- W3137160368 creator A5015474460 @default.
- W3137160368 creator A5016727275 @default.
- W3137160368 creator A5017081556 @default.
- W3137160368 creator A5018782244 @default.
- W3137160368 creator A5020422859 @default.
- W3137160368 creator A5021194282 @default.
- W3137160368 creator A5023521085 @default.
- W3137160368 creator A5028015663 @default.
- W3137160368 creator A5031455285 @default.
- W3137160368 creator A5036369768 @default.
- W3137160368 creator A5041440753 @default.
- W3137160368 creator A5042218159 @default.
- W3137160368 creator A5042648817 @default.
- W3137160368 creator A5045653507 @default.
- W3137160368 creator A5051200107 @default.
- W3137160368 creator A5051480539 @default.
- W3137160368 creator A5053911309 @default.
- W3137160368 creator A5055518755 @default.
- W3137160368 creator A5058805192 @default.
- W3137160368 creator A5063626071 @default.
- W3137160368 creator A5067760529 @default.
- W3137160368 creator A5072351798 @default.
- W3137160368 creator A5075987263 @default.
- W3137160368 creator A5076320154 @default.
- W3137160368 creator A5085588881 @default.
- W3137160368 creator A5088352466 @default.
- W3137160368 date "2020-01-01" @default.
- W3137160368 modified "2023-09-23" @default.
- W3137160368 title "Therapeutic Response of Patients with Chest Tightness Variant Asthma: A One-Year Multicenter, Prospective Real-Life Study" @default.
- W3137160368 doi "https://doi.org/10.2139/ssrn.3588591" @default.
- W3137160368 hasPublicationYear "2020" @default.
- W3137160368 type Work @default.
- W3137160368 sameAs 3137160368 @default.
- W3137160368 citedByCount "0" @default.
- W3137160368 crossrefType "journal-article" @default.
- W3137160368 hasAuthorship W3137160368A5000830943 @default.
- W3137160368 hasAuthorship W3137160368A5001969147 @default.
- W3137160368 hasAuthorship W3137160368A5003889868 @default.
- W3137160368 hasAuthorship W3137160368A5005975071 @default.
- W3137160368 hasAuthorship W3137160368A5006063703 @default.
- W3137160368 hasAuthorship W3137160368A5012677271 @default.
- W3137160368 hasAuthorship W3137160368A5012718640 @default.
- W3137160368 hasAuthorship W3137160368A5013429539 @default.
- W3137160368 hasAuthorship W3137160368A5013624090 @default.
- W3137160368 hasAuthorship W3137160368A5015474460 @default.
- W3137160368 hasAuthorship W3137160368A5016727275 @default.
- W3137160368 hasAuthorship W3137160368A5017081556 @default.
- W3137160368 hasAuthorship W3137160368A5018782244 @default.
- W3137160368 hasAuthorship W3137160368A5020422859 @default.
- W3137160368 hasAuthorship W3137160368A5021194282 @default.
- W3137160368 hasAuthorship W3137160368A5023521085 @default.
- W3137160368 hasAuthorship W3137160368A5028015663 @default.
- W3137160368 hasAuthorship W3137160368A5031455285 @default.
- W3137160368 hasAuthorship W3137160368A5036369768 @default.
- W3137160368 hasAuthorship W3137160368A5041440753 @default.
- W3137160368 hasAuthorship W3137160368A5042218159 @default.
- W3137160368 hasAuthorship W3137160368A5042648817 @default.
- W3137160368 hasAuthorship W3137160368A5045653507 @default.
- W3137160368 hasAuthorship W3137160368A5051200107 @default.
- W3137160368 hasAuthorship W3137160368A5051480539 @default.
- W3137160368 hasAuthorship W3137160368A5053911309 @default.
- W3137160368 hasAuthorship W3137160368A5055518755 @default.
- W3137160368 hasAuthorship W3137160368A5058805192 @default.
- W3137160368 hasAuthorship W3137160368A5063626071 @default.
- W3137160368 hasAuthorship W3137160368A5067760529 @default.
- W3137160368 hasAuthorship W3137160368A5072351798 @default.
- W3137160368 hasAuthorship W3137160368A5075987263 @default.
- W3137160368 hasAuthorship W3137160368A5076320154 @default.
- W3137160368 hasAuthorship W3137160368A5085588881 @default.
- W3137160368 hasAuthorship W3137160368A5088352466 @default.
- W3137160368 hasConcept C110586980 @default.
- W3137160368 hasConcept C126322002 @default.
- W3137160368 hasConcept C142724271 @default.
- W3137160368 hasConcept C159110408 @default.
- W3137160368 hasConcept C188816634 @default.
- W3137160368 hasConcept C204787440 @default.
- W3137160368 hasConcept C2776042228 @default.
- W3137160368 hasConcept C2779951463 @default.
- W3137160368 hasConcept C2780333948 @default.
- W3137160368 hasConcept C2781142857 @default.
- W3137160368 hasConcept C71924100 @default.
- W3137160368 hasConceptScore W3137160368C110586980 @default.
- W3137160368 hasConceptScore W3137160368C126322002 @default.
- W3137160368 hasConceptScore W3137160368C142724271 @default.
- W3137160368 hasConceptScore W3137160368C159110408 @default.
- W3137160368 hasConceptScore W3137160368C188816634 @default.
- W3137160368 hasConceptScore W3137160368C204787440 @default.
- W3137160368 hasConceptScore W3137160368C2776042228 @default.
- W3137160368 hasConceptScore W3137160368C2779951463 @default.